concept

ALPHA-SYNUCLEIN AGGREGATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALPHA-SYNUCLEIN AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

33Connections
4Hypotheses
1Analyses
13Outgoing
20Incoming
0Experiments
1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameALPHA-SYNUCLEIN AGGREGATION

Pathway Diagram

graph TD
    ALPHA_SYNUCLEIN_AGGREGATION["ALPHA-SYNUCLEIN AGGREGATION"]
    ALPHA_SYNUCLEIN_AGGREGATION -->|"causes"| Parkinson_s_Disease["Parkinson's Disease"]
    ALPHA_SYNUCLEIN_AGGREGATION -->|"causes"| Neurodegeneration["Neurodegeneration"]
    ALPHA_SYNUCLEIN_AGGREGATION -->|"causes"| CNS_Inflammation["CNS Inflammation"]
    ALPHA_SYNUCLEIN_AGGREGATION -->|"interacts"| Mitochondrial_Dysfunction["Mitochondrial Dysfunction"]
    Short_Chain_Fatty_Acids["Short-Chain Fatty Acids"] -->|"modulates"| ALPHA_SYNUCLEIN_AGGREGATION
    BMAL1["BMAL1"] -->|"promotes"| ALPHA_SYNUCLEIN_AGGREGATION
    Piperine["Piperine"] -->|"inhibits"| ALPHA_SYNUCLEIN_AGGREGATION
    ceftriaxone["ceftriaxone"] -->|"inhibits"| ALPHA_SYNUCLEIN_AGGREGATION
    Polyamines["Polyamines"] -->|"modulates"| ALPHA_SYNUCLEIN_AGGREGATION
    Ceftriaxone["Ceftriaxone"] -->|"inhibits"| ALPHA_SYNUCLEIN_AGGREGATION
    SNCA["SNCA"] -->|"involved_in"| ALPHA_SYNUCLEIN_AGGREGATION

Outgoing (13)

TargetRelationTypeStr
Parkinson's Diseasecausesdisease0.95
Parkinson's Diseaseassociated_withdisease0.95
Mitochondrial Depolarizationcausesphenotype0.93
Dopaminergic Neuronscausescell_type0.92
Parkinson's Diseasecausesdisease0.90

Incoming (20)

SourceRelationTypeStr
SNCAinvolved_ingene0.95
D-520suppressesdrug0.90
SNCAcausesgene0.90
Short-Chain Fatty Acidsmodulatescompound0.90
Piperineinhibitscompound0.90

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
m6A-dependent control of alpha-synuclein transcript fate and 0.626 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Cell-state stratification is required to resolve m6A RNA Mod 0.612 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Glucosylceramide accumulation nucleates alpha-synuclein aggr 0.525 Parkinson's disease GBA-Synuclein Loop Therapeutics for PD

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.907

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning ALPHA-SYNUCLEIN AGGREGATION in their description or question text

No additional research found